PFS Partners’s VivoSim Labs VIVS Stock Holding History

PFS Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$182	–	365
2021 Q4	$182	Buy	+4	New	+$257	﹤0.01%	342

Other funds holding VIVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFS Partners's VIVS Position: Q1 2022 in Review

PFS Partners sold out of VivoSim Labs (VIVS) in Q1 2022, closing a stake of 4 shares — an estimated $182 sold.

PFS Partners first reported a position in VIVS in Q4 2021 and held it in 1 quarter. The position peaked at $182 in Q4 2021. 37 funds tracked by Wall St. Rank hold VIVS as of Q1 2022.

PFS Partners reported no remaining VivoSim Labs position as of Q1 2022 after selling out during the quarter.
PFS Partners sold 4 VivoSim Labs shares in Q1 2022, an estimated $182.
PFS Partners first reported a position in VivoSim Labs in Q4 2021 and held it in 1 quarter.
PFS Partners's VivoSim Labs position peaked at $182 in Q4 2021.
37 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2022.

Based on PFS Partners's 13F filing for Q1 2022, filed 1 Dec 2023.